Considering the significant heterogeneity among studies, subgroup and meta-regression analyses were performed by focusing on the study region, cancer type, clinical stage, sample size, the proportion of patients with low NDRG2 expression, and analysis method to explore the sources of heterogeneity for OS (Table 2). The gene discussed is NDRG2; the disease is cancer.